...
首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF-beta 1-stimulated primary human fibroblasts.
【24h】

Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF-beta 1-stimulated primary human fibroblasts.

机译:IL-13对TGF-β1刺激的原代人成纤维细胞中金属蛋白酶1的组织抑制剂增强的机制。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: TGF-beta induces expression of tissue inhibitor of metalloproteinase 1 (TIMP-1), a potent inhibitor of matrix metalloproteinases that controls extracellular matrix metabolism and deposition. IL-13 alone does not induce TIMP-1, but in combination with TGF-beta it augments TIMP-1 expression. Although these interactions have implications for remodeling in asthma, little is understood regarding the mechanisms controlling TIMP-1 product. OBJECTIVE: To explore the role of Smads and mitogen-activated protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) in the TIMP-1 augmentation by IL-13+TGF-beta1 in primary human airway fibroblasts. METHODS: Real-time PCR, Western blot, ELISA, and transient transfection were used to evaluate the mechanisms of TIMP-1 augmentation. RESULTS: IL-13 enhanced TGF-beta1-induced Smad-2 and Smad-3 phosphorylation, transient transfection with dominant-negative Smad-2 or Smad-3 decreased TIMP-1 mRNA expression in the presence of TGF-beta1 and IL-13+TGF-beta1 through inhibition of Smad-2 or Smad-3 phosphorylation. ERK phosphorylation was increased by IL-13 and IL-13+TGF-beta1. MEK-ERK inhibition decreased TIMP-1 mRNA/protein to a greater degree after IL-13+TGF-beta1 stimulation versus TGF-beta1 alone. MEK-ERK inhibition also significantly increased Akt phosphorylation under all conditions and decreased Smad-3 phosphorylation in the presence of IL-13+TGF-beta1. In contrast, phosphoinositide-3 kinase-Akt inhibition increased phosphorylation of ERK and Smads, leading to increased TIMP-1. CONCLUSION: These results indicate that IL-13 augments TGF-beta1-induced TIMP-1 expression through increased Smad phosphorylation. These increases occur as TGF-beta1 downregulates IL-13-induced phosphoinositide-3 kinase activation while leaving the positive effect of IL-13-induced ERK on Smad signaling. CLINICAL IMPLICATIONS: This augmentation of TGF-beta1-induced TIMP-1 by IL-13 could contribute to the fibrosis and airway remodeling seen in the presence of T(H)2 inflammation in asthma.
机译:背景:TGF-β诱导组织金属蛋白酶1(TIMP-1)的表达,金属蛋白酶1是控制细胞外基质代谢和沉积的基质金属蛋白酶的有效抑制剂。单独的IL-13不会诱导TIMP-1,但与TGF-beta结合会增强TIMP-1的表达。尽管这些相互作用对哮喘的重塑有影响,但对于控制TIMP-1产物的机制了解甚少。目的:探讨Smads和有丝分裂原激活的蛋白激酶激酶(MEK)-细胞外信号调节激酶(ERK)在人源气道成纤维细胞中IL-13 + TGF-beta1增强TIMP-1的作用。方法:实时PCR,Western blot,ELISA和瞬时转染被用于评估TIMP-1扩增的机制。结果:IL-13增强了TGF-beta1诱导的Smad-2和Smad-3磷酸化,在存在TGF-beta1和IL-13的情况下,以显性阴性Smad-2或Smad-3瞬时转染可降低TIMP-1 mRNA表达。 + TGF-beta1通过抑制Smad-2或Smad-3磷酸化。 IL-13和IL-13 + TGF-beta1增强ERK磷酸化。与单独使用TGF-beta1相比,IL-13 + TGF-beta1刺激后,MEK-ERK抑制作用在更大程度上降低了TIMP-1 mRNA /蛋白。在所有条件下,MEK-ERK抑制作用也可显着增加Akt磷酸化,在IL-13 + TGF-beta1存在的情况下,Smad-3磷酸化也降低。相反,磷酸肌醇-3激酶-Akt抑制增加了ERK和Smads的磷酸化,导致TIMP-1增加。结论:这些结果表明IL-13通过增加Smad磷酸化增强TGF-β1诱导的TIMP-1表达。随着TGF-beta1下调IL-13诱导的磷酸肌醇3激酶激活,同时保留IL-13诱导的ERK对Smad信号的积极作用,这些增加就会发生。临床意义:IL-13对TGF-β1诱导的TIMP-1的增强可能有助于哮喘中存在T(H)2炎症时出现的纤维化和气道重塑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号